Interim FDG-PET has no value in selecting patients who require treatment modification in both early- and advanced-stage Hodgkin lymphoma: response to Adams and Kwee

被引：2
|
作者：
Dann, Eldad J. [1 ,2 ]
Paltiel, Ora [3 ]
机构：
[1] Rambam Hlth Care Campus, Haifa, Israel
[2] Technion, Rappaport Fac Med, Haifa, Israel
[3] Hadassah Hebrew Univ Med Ctr, Jerusalem, Israel
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2018年 / 183卷 / 01期
关键词：
Hodgkin lymphoma (HL); interim PET; CT (PET-2); radiation therapy (RT); early-stage Hodgkin lymphoma (early-HL); advanced-stage Hodgkin lymphoma (advanced-HL); ADAPTED TREATMENT; TRIAL; THERAPY; INTERGROUP; ABVD; CT;
D O I：
10.1111/bjh.14905
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：131 / 133
页数：3
相关论文
共 50 条
  • [1] Interim FDG-PET has no value in selecting patients who require treatment modification in both early- and advanced-stage Hodgkin lymphoma
    Adams, Hugo J. A.
    Kwee, Thomas C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 183 (01) : 129 - 131
  • [2] Controversies on the prognostic value of interim FDG-PET in advanced-stage Hodgkin lymphoma
    Adams, Hugo J. A.
    Kwee, Thomas C.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 97 (06) : 491 - 498
  • [3] Hodgkin lymphoma: is there really a need for interim and end-of-treatment FDG-PET evaluations? - Response to Adams & Kwee
    Mesguich, Charles
    Cazeau, Anne-Laure
    Bouabdallah, Krimo
    Hindie, Elif
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 (01) : 124 - 125
  • [4] Response to the letter by Adams and Kwee, entitled: "Unproven value of end-of-treatment FDG-PET in Hodgkin lymphoma"
    Hindie, Elif
    Mesguich, Charles
    Bouabdallah, Krimo
    Milpied, Noel
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (11) : 1937 - 1939
  • [5] Response to the letter by Adams and Kwee, entitled: “Unproven value of end-of-treatment FDG-PET in Hodgkin lymphoma”
    Elif Hindié
    Charles Mesguich
    Krimo Bouabdallah
    Noël Milpied
    European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 1937 - 1939
  • [6] Interim FDG-PET does not predict outcome in advanced-stage Hodgkin lymphoma patients treated with BEACOPP
    Adams, Hugo J. A.
    Kwee, Thomas C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 (04) : 758 - 760
  • [7] FDG-PET for assessment of early treatment response after four cycles of chemotherapy in patients with advanced-stage Hodgkin's lymphoma has a high negative predictive value
    Markova, J.
    Kobe, C.
    Skopalova, M.
    Klaskova, K.
    Dedeckova, K.
    Plutschow, A.
    Eich, H. T.
    Dietlein, M.
    Engert, A.
    Kozak, T.
    ANNALS OF ONCOLOGY, 2009, 20 (07) : 1270 - 1274
  • [8] eAssessment of Early Treatment Response after 4 Cycles of Chemotherapy using FDG-PET in Patients with Advanced-Stage Hodgkin Lymphoma
    Kobe, C.
    Markova, J.
    Skopalova, M.
    Klaskova, K.
    Dedeckova, K.
    Pluetschow, A.
    Eich, H. T.
    Dietlein, M.
    Engert, A.
    Kozak, T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 (SUPPL 2) : 252 - 253
  • [9] Assessment of Early Treatment Response after 4 Cycles of Chemotherapy using FDG-PET in Patients with Advanced-Stage Hodgkin Lymphoma
    Kobe, C.
    Markova, J.
    Skopalova, M.
    Klaskova, K.
    Dedeckova, K.
    Pluetschow, A.
    Eich, H. T.
    Dietlein, M.
    Engert, A.
    Kozak, T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S252 - S253
  • [10] EARLY AND LATE RESPONSE ASSESSMENT WITH FDG-PET AFTER BEACOPP-BASED CHEMOTHERAPY IN ADVANCED-STAGE HODGKIN LYMPHOMA PATIENTS HAS A HIGH NEGATIVE PREDICTIVE VALUE
    Markova, J.
    Kobe, C.
    Skopalova, M.
    Zikavska, L.
    Vernerova, Z.
    Klaskova, K.
    Dedeckova, K.
    Eich, H. T.
    Dietlein, M.
    Fuchs, M.
    Engert, A.
    Kozak, T.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 33 - 33
12345